%PDF-1.7 % 11 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20210618155525-04'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 12 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 6 0 R 7 0 R ] /PZ 1 >> endobj 12 0 obj <> stream xZ]o6}CJ>Sd-ҡhxðEKZ%ѕd{?ڿܥ(J."ÈϽKS<`/D}xzo0~ : .<S=G@I9>}[?Hx[w0)7Ds;D =cQ_9=TPGZWuZ&|FL/  HFsYU"UπoUQ酜Z{2x/Pr DIUq*k4RUCv؂^:zplp~7U\LO(w xprH@{S#nHç1p:< 9| IDŽg ɾ2ogCu+ehH;Zze82;N z2$5Y lK u)TKN\7lS u5ΧX8'i=B/ '*O2˖ C mѬlK xH.M*e6"=>/$NqݩqIEjX95 E~9e z -Ԣ 81bCBGLˆI:N QILA3jY*Z$IIL J֙kJJ2Je\2g jSբN'K,}zLEK)!T K9,0vO/Ǔ:o梡.=N_Ʉ/IoJ8xjc']m˽9RųLֺ siaf:>\tn@B N-DKRV+G8议x5uB3wWy#`j+u{wdג[Gx~]Wu"GSKf-VKnצvZg96ti]Tږ+u5W *l`'.t˪kqP|n; 0 <"0^ҽc, }fqw"́M֭Us#TG?RքRꞍkp[¶"9N[ ZЩ+`\ez!Tri%1RZZuQ'<3v0-ӱjdª5ԳCt**Y sYX4΀kUzs q:WY'>0][vYY ZhVsS6lR6WHF;Z)r0 ^U4İ笚5[Y :oP-BK5ωɦ ۛE> /Annots [ 8 0 R 10 0 R ] /PZ 1 >> endobj 14 0 obj <> stream xVMS0W`E-pKK N34,w L#KZ{O(!P8.O%QBo#& O\p]BI>%<4d ow\']a}ćc58h{`ݔ>#܍CrȀcyAQp'<u`'gz݃ 7 Kt:h[>qFg# BUGpr<_(ʲ3V1E5 JC*n*ƳT!.?0ꆇ-{y][FWZ &> MN;0\ȵ*%_M} iٌ7S7Ga)E?MC2U+5CN.RGnG!qAt{ŽS$f̢sP .!߮C*=p{xnq{e)*6˙LRV޴k0 2Uu1:fi5<-4쮷L%ԭU#AP65ӊ9`?Lu6=J-|T($-J> endobj 3 0 obj <> endobj 5 0 obj <> endobj 9 0 obj <> endobj 15 0 obj <> stream JFIFHHExifMM* z(1>?QQ Q HHPaint.NET v3.5.10z%u0`:oCC." }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?(f 1T$`9Sw(B@;~(]Cd꾫Es:aݻd2\(2F][&]ۢϲ|W͵L@A A 8 (CĝCglZE/ |Ezє{ xQʒ@[ྊ\/I4R0?6.7`ŴwPu|3/Z@Ogi}cFdFKoj?~8|p_A<ĺOkGPK $wRmkmF;YVx&rLj#p ׭axf|s$Ӿc:Qwm]N)Cψ[eYba98xB+oTÚwcRþ$U[ ?qΙ{&jv6Xo$=ԗ&7zgAxIִ.$3,mwc{+%g[!U@&Fϻm/#hci'7n[%It.&/ֶ+Zl~:wi~D>$}o+}@.[/+B6mnt8bi{zc.~F{eUe86g3 VT&> BK VؘXzSMesoM_&ϔIÍK?+hڿnt_ K]H '̽yrWA=O+|"!gɤItXe>Xs hwwG Eouqa /ş_~~'x} ]_^]/ 蚼:<cu/ h&omEۯicǪ\[,k}_uS}㏆W]G^tmf`Ks ]=va&h9n忔>75NWQτ0of,E (˰8hBC_ Jq'W UQKz,N>+`S%}b5ISJ]+(&QVN>eoy7xG4[]]3K{i$I>g-(mbynLIC,"*3f?-%`lfPx涽X"H'h"ֈ(TfeU:܉,a,R*I4xcxalOhGр|ia$cg,{gAHEu->]F,{-.,EX"I$XQD/3R.{{T&ҭ%4[OPnx"HhM :e}-Լ'=s:\iZ<+Lj5+1AɮLZx-☽G3 1I"kuχ+A}5'NxI8 gJk[oenm!x,=n=>}kjPx~M񧍼5k45a,RLiȖTFQMR&K;}r+XkY[y>2F=2~6>Gmi++<[WF76MH4>;;Kf۽ъM3ZE}c㿈*- -.|G5uI![ YR$$A>Eyׇ|7u;n>4׭JϷR[h!rVr\{~Ϛ >0jMg?_y_ Do/x;ÚƏi a𶕦f|Eqgk4V^RY]}F,/J%ՌAud%:x3Hg_4[+^ ҴKaXF'n.]Z(i$bef5GO:u]/a~.3N4xiG*a8ާ-U){G nJEڿ[m7wv5MYp|'gm # #%B?|鿲w­{+_|Q#VkxcZޛ{I]Wyak}..i˨iY9QwOA~hf{+ |Y;cڴ27G>|H,na8o; CEO,ZLP?SHK} e92W7/1aj¤aڄq4 қS7,5]%EƔc/uҒw\r/EnT y>!V+VK4X^Y{;+Ӫ=MqslEn?Zz'Ë}^2xĺGf70/M~*DU=坍G{wwvci%vZ$GY&J9dkՀ\6hs.F*ĩ"+S%s*{ qqDj3$ q^T24,Cn +=j񟍼q5k'\%ݎ{ͦuyq4X$y<ك2Ey%™|Icw]3#R[`{KցY [1*kLOdw ^OAkЏb<¿ <=6x0ׄ>(=*[ t]9-?IZ@}/>FۃQ@ endstream endobj 16 0 obj <> stream JFIF``*Photoshop 3.08BIMUHONSFDA-Bladder Cancer DruggNYBZ124s AstraZeneca720170501< 190456+0000 5xThis image provided by AstraZeneca shows the company's drug Imfinzi, known chemically as durvalumab. On Monday, May 1, 2017, the Food and Drug Administration approved Imfinzi, part of the new generation of immuno-oncology drugs, which help the immune system to fight off cancer. The FDA also approved a companion diagnostic test for identifying which patients are most likely to benefit from the drug. (AstraZeneca via AP)nAPt AstraZeneca(AP PROVIDES ACCESS TO THIS THIRD PARTY PHOTO SOLELY TO ILLUSTRATE NEWS REPORTING OR COMMENTARY ON FACTS DEPICTED IN IMAGE; MUST BE USED WITHIN 14 DAYS FROM TRANSMISSION; NO ARCHIVING; NO LICENSING; MANDATORY CREDITFAExifMM*bj(1 r2i``Adobe Photoshop CS5.1 Macintosh2017:05:01 15:04:13Р"*(2HH Adobe_CMAdobed            L" ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?TI%)$_8NǴDvSi$d NGE$/\ H=!ۘXlk5N.w)*2QekFy"JY*a۩p<s5J2ŃsC\F8HڤrAsց$rLEV$/] OZDueeԱsߧ51Dn BclI$TU}:[K=e%6W/2F%9lsv2g6o[)72|=F7vIՅvѻO*tNB 0tz= \ƽ @{F8޹q,r3Yye]%{k9EtSgUܪ{hsZGu7vOrϊc" ~;OPo};Ye7O&lwީ2? V*sGN֧9'T=C$]i0^ֽi}_9}+6Sf߽+kT}ˎkށ~r\Pq:_> 8knw~Ĥjb.+tV9YMc MYA=f>MbqQ[ kC`Q`c"r:v)Qa8RLlUΉutp[ma v[cd:.e[npsZ ZǶfoƿj1AGwE ma kuu]W:}I Fmp1Y~*FV._n31jmnM>;DO)qkv8=Nc:Y`qa..jZ},YC{zOt.7֥m'dtLF_l־w^[ T2Ld봗9w:Eߚv0GpHݳl Ź4gۻf׮ցdmfK㕒3RmwjC ƙN[eKֈȵUEִ ƾ~ng= |>%ݻ`<Ѱ s;zH&}#o"(Ջ nm;[QiȻ9Mƶ185o \`m T+n8$ q3*ݽcYGQ6?Hjsדꃻ)wߡGfHV_Vpі4f˱m{mb'ճ04w2ok}%f9>sn{ZTg86֟mlvS(mk9\@8fIl1vړb~eUu&V6=:1什6#Sm;{٨mbib<,͇nonH/ʬU)?Y;洖Y^i)?iu6#0wWٳEW:lnnV3XCpwbQUJ$@zlå~ֳ;%!;?Gn,Lm/OUx{+lEFIu :`ۖ*Yex|9оݺ}k?,Z(]Pf;`ݮ[3=3J뺣c}~*},lo{gZp稆Ɏkǯn[KFN-]MikKdVݞ{?-UU=YMYhi浩Kk[6F\0 G iN&﫝!q;~mh{g8$om?YXxTYUtaip)mf] ǿWBj̤AI#"Lf $Ա]W\̿^Nv]=0T-Ť<;wlDzkn]cMs[Z-k89"*$'%DgQ棢q$;#snȮk'6QmW:~OP,UP==lk~vr[?f_/3r++0x4?AU'(1q麜֛Z6^ݑp [k@nߤV׍pqRY 0tz-q춇ߴ?ԩ,_XzDnkYEKE^!}Ea̧=c]J@LїW>FE=3" pc{en9^3v]c x{,߽OWwYK1hݷ=}Ub_Ѻ}Vn5g}J]ї$vHˇ};!K&:48CZ\H ?mv[_oS[G%oIa$5׌ׇ v=[*_MjGPcmyh{_0՗WJ^RZ+Gݯw !W!\ 1:WL|aN?c[k6U:ey^kLmkOѭ6LR/7^#MG5(a}ꃕCGkZƆ4CZ'I#}T+I$I%)$IJI$RI$I%"Zgw}VRD_Dꁘ5ėGI$H@ICC_PROFILE0ADBEmntrRGB XYZ  3;acspAPPLnone-ADBE cprt2desc0kwtptbkptrTRCgTRCbTRCrXYZgXYZbXYZtextCopyright 2000 Adobe Systems IncorporateddescAdobe RGB (1998)XYZ QXYZ curv3curv3curv3XYZ OXYZ 4,XYZ &1/ http://ns.adobe.com/xap/1.0/ A This image provided by AstraZeneca shows the company's drug Imfinzi, known chemically as durvalumab. On Monday, May 1, 2017, the Food and Drug Administration approved Imfinzi, part of the new generation of immuno-oncology drugs, which help the immune system to fight off cancer. The FDA also approved a companion diagnostic test for identifying which patients are most likely to benefit from the drug. (AstraZeneca via AP) FDA-Bladder Cancer Drug AP Item Id b2836744-65cd-4061-8fb6-6b108bd02257 AP Friendly Key 17121686967379 b2836744-65cd-4061-8fb6-6b108bd02257 AP C  !"$"$C V !1"AQ2aq#BR345bcr$7CSt%Tsu6de>!1AQaq"2B#Rr34%5Cb$ ?.P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(EP#P1@VGCzA8Ƞ*h P @(L @Sz}GKh @( @3@3@3@2=hP @(P @()ej8I<ԭ0-M 0JJ2c#Q[iuSo(^>xvHfe ޡ—Hc>6fe4.qA!D Τv,djYꟺTj0'?aOM _'a>h?p([.Iap_+)b?|js pgb}4?ذgGg` !e 8j.IZh ;J$z=?dLch;ؘŊm' Nqb jH')XTu|cƬ9_wf*$c?u._珺CP>hH9?4~r:hgtЁxM *7琜|!H%ih"*ZTH[-Hu=y232RǨ~vHfeY:}&禍X+@(P @(P @[YꚘCZ 9wdJBd N'IAoMy4r8N)uLM2YorVV}z^\!z_RxҪܕH$F>+2q]qq(%)r@VH4V6q!m)Kx66Iw~@°"gcKwxMy-H-kJ*ߏ9 nfK-=&WE)(IQ I_Ԍq,/F?D[ *Ҡm99 $ mP(jdFLEGz:Dg32Ж/r򤔨mWN:,)Z@( zGsym)-$mQ[9IkMU:2aF[XRTSm$k)^䥒ڗ }o+WkA&B{)!8% c( ZeZJtM޿9y=(AQVJ dx'E?'Y/H*ڣsn% @!VvcqcWV-)tz`y@vQaNj+HdttrTߗ!Jv#[D}=k2ڦ(3 8w%#ô~PQ%@i͖P]NL:. qB6"{8( H”lܫ3P @q4IbK4ۅ; R3x֫c5es\ZLK2zUWwKVr!K˲g5LJzqέ {(*$0B\_$+>*QkZ@(P @(P ̯Tգcj+7g\^j3[xhV*BI q6]sqjtVIKƯ ⺯}=jd Q3u=k?nu|ڽ{yNu|!۽\{QNH㯭VP:|Y֪ԍtj%S_kUkڇ&]r42-`NRÇ#yeXuk/;m7~ßڔ!"K KmH9R@$:`Gi_t̩ZC4!V?9<򱚴NmP @(P @(jPg?j܇krr줠%ax ~+&V&Cug{I\wYܢHpA8'09rXhMvMuݐ`6cpb,OX%QgjqW.}?#y}Pⷪ|L)Z.))%(qұRcMkLob1aKԯ(dU5NMIjSW<^R#v"xOw7[o M}~x]>64~782z7Khie͌GP2C$MZVq"{:?^wW𶠵b|ԚI9k1P,777Uzt^ˡj }vs5 %( +OwP\VxJ1eR g{[^w@[^Z9n7uB ꬡ_2T8;8Ÿɢv+vt8P;>E%)գ,&2V,̿SikXKmET_;m(p8 QJ=M^woVy[F8Z0}5-v'iޕ%J)D(/֭K8I>#;t_DFC>bO_K'_vԳJky({)&4] U${+IlQ'9(eaል[Ħ(ۯ?d6*> w- >IyU8)UGL'X.P9%3ݶ2J\8PJ;T@>jT<%XG39\XBS  dȩ[ lgHc Mj|4/<'T{eKiO~𴅡Ei@xspJM~ϟqvHBf7GlZ ӯJzenhٽ\e%Bc8n#'WSm|t*3P @(P @(CYꚴw!hBaJBah t<1tSJI8fFexyŶ⧟RCI k.%Gh%\xw#Hy\;Mp5Ƕpd#8KxޭyYwpJnxGiw.Y&6EoTbfƩpM91헛++}a( t!*=waa`~lLԕ&>͵5u3{a !ӱW FJHxF1MbSmJ~@ "1XWQ{4F|W/r) p}Gw'Ѩ_7mփL;B!.:6Sp2Wj+fxJ33Z|}4Wb-ɠLި8JR6xGJeRc/ԅn_ƣ3SrqNB[ x1dUenG~x'۫=>:mOm#"1, WQ?}OMuMZtGA@1@kݢ&BfPq9y6g֍kH%FCy4Á3$``Wct[P%}2zEiFPO)MU x5=:Z_H\X-*mVOxd7-88iiVFF@9)տp Z/2]GJR\%NJ\_wNw(7 v,3tIVr8I>gjG>uU%-;%EJ$Dݐ?GUW;S z %5^ӒBz(5xISŹG0u!v*(K9R-g9ܠ >X_IYdϝL{=ĉV(Oq$Y<`qבבQe/Z70^>$G, 3#a=O`'?jt9eI|,ˊ̓.B6/–=ISSS۵]z$ESwC[*qm~Vz5\U9Zx+#O7ȭy=Ʒ]4vܥ< Σ fp|< $._vFu:LD'jnB׵-(6HQ88x{G7.cߏku`$1ĕo ۜqVzDs@(P @(P Ԯc9SV臱} Z  JA#nlaN;E(i’{z]nn34Ѵ᭵ psJ݄@#ĸW}&s(izߙ.gњ[2)=Э;3X D) " "ANsݔcMZ +n 6XnSLyAJPSlBRp TVAVj ?6r3!Ȏִ82Yڕp0jk&I]w  qB@ ֨NdHǴZ`;!^,*Q󏩨SقmؒĨaЕf~'`k};-Q9ہһ]6ҒlT,( bo$wRRfD.<,i3Ik FGVl a۰S ;KN:rJw5 'jw*nhb4@ty 끒z sIƚ^$ظ5y qc:#i 4Tۻڀc^~UQhk!_O~c޲NqF*ǘVx){J7sjȐoN<܀҆qH>dYxse;-i[R $J'RQݙ= ƖډlͰ_iD϶8'O$y#<_kez8$F޽Nj4< K~bt$:>=[?oU3˒VTQIH c|*f=ډ(̭P @(P @(fWg>F{;}(lsc YW8!YҴ$7_TKXXl%[R՟h^pUrk ļ4SWע|dK`8Oz_ez0?ZNhʭNo׺i(L$|>̺gitRm\ej1#rg/[sjPSvٚLP\ #=2;ʧc'ֻ챼mі޿֪vpe.;%Vdcv[r zNt* JW# q\l/$z*:}t"~Ҵ5&a<~%RO1FDX [I?$]qN̕-, #gVK-S1Y,`,2gPa]]1M*q!HHYHIQ*s\ቤVd-׊B)Q ~r4lUtH $MF~I?I܈8QU[Q iOIB'IT~S4z|}ˬOpT^=>`v>3nBe ׅx΢Z:q?zQKH%tOAq4MPs7&ޑR2 J⪏3xa0BXFqh{Mu:d0bCaWhl+*݂z$tKc'f{5Xx怦h @(j-9iUhZ66>l~1)Ԯ kص3~Y A  #E.lku)CR-$%8O#DsdnM"HCo_ Jҙ4 %a%>y1.Pk4TZSyeܟ;~TlVwD%&I;g: b$:H }M萆TBJKpw`wRu+CDX\5w,&8 R*Y.WF TpHq?t peXNww Lvwje:;b[r-J/omI ICd( nZ1on?@IzKZUW<3^̗])JH'6H%R)E:i K-"ozc=g?ixJ|\Y ڝ[Jҧ *$*QRRHQOShĶ!_DVIqӕ:gg,lBRIj座Sʻ#-ݙ+tr?*Tcbud\z԰zҀPJMCŐ"ڑ44R!$Qr0NOD*TS[YeSLj$)!4RBN,TR:COcJjD%hljWJ@RQU-Hg񣴈S{'hx d ŧP. mƕ)mF-)mބm8OZ;_A!^vKR҄'r3xsɩKڎādv:T؝SHڠIV[YV$iH#uzՖd_ҬQلOJh҆ V8y>sS_6h:1SYtkR8lq>"`[PR};M91Zq!; ط{vxA:U:ϛ]kcS4LR;BN;mH`㍾*B~np#S.0K)?W~nOrz|+jpJF4BbXiCU+9YךJݩ.2dE0!Ɗz(Rwp@9}Nl^);X֢ΡqnB)Sf1xx~b Y& *h0 !c' u­kBrYCGjpAh叾Z;.T:AL{)7)2:"P @(vewҥ$m\)m\:}(h|jIq'ѭ3̏CRYBuOfU;7\ie_}Qٟj3#b/T!qeR6i'$S+M\'}8ZLDO]!4qBV'ҕc:k٦#ZEoVv[u*Dllww,a[Rr$wW4WS)`{*qze~cҼZcEmWsʼnlCyTRIһ,hq;N ܽe)Mm9%JHOWSUNǹ]X[Q.O&)i1; WHczz$evOi.[n8!x<[;ьzi,+nrϬ+xcI]Gu,&:ON Nc@Zu~vUHЎ [p)[Y*ʆ3`iQi 0o=y+{HR.ZV$xBSCsU(% *kN(wvM6Y_(g.n=FR\l⣥>,I#O8yx{蝵{EqZ0ۡ*BcyNFU'& YD~qnw?O%d((8:'x%( 2G 5e1~ҚbK~/ʵ+"Z4 G )'y<\TCA@SΤu@]Dx-B8LJh$#vxtSVv/V̖]趬e\n;ω{$q,UFmْ:ܖZ]C \+skN|#> Yb$՜W4Aԝ]t܈/B;W̭-H,[>4ӵ"j±+$$dO eק/jŋXd/$2ފs%d)ǻ'ˎJ-VU픵xSB/) ps1̩avm6L\\IG$;ÃIb6ởjL^Ѧ2K eUg*0j\h57cɀ"+@.2 BG^|J@I%/>uhݑrI5de!EK)ܰ \4Q*,jMD S!-JTA)H8mBF9]E S) %JvT3"Ur}1`Ohr$.g [(JJ$Q:LvJ~lˡ9Ig[im5骺3zNtI?eGc>:\=sPqלVRI(3'2rR 7P @(ecD;)j H'W@({Q^Fx8s $+[#$qV$<p9p,C:ѥcN?96JR\ ?Ծ@-h-snv5ـxBU# qoqД'TI|_qlsf*x23qqԥ'v@y4]+7zҘm;x)IF zF&R7py  GS|Nɾ$+RHfE6YH3 -`)D| i٫7}*IbPߦ9 O8wNdm'7 WԸEs-*PIܷ:q if.KaiNFqԵJtG&k6$T(Ä-={TՅ Z Fը$9=RN%RUݤ9=XgF+yxnkʖHw%<cN)Ѿ(;Ҝկǖ-( JJs<(6'X\$)l׺R27c#FhGIuR$3-J%ܜLq0Um*7WD--u,({~Fr:j̊QYeSqji{G<<ْ W_W؜FAscilӉ)Z[P9n椚@C@$m~Vm$\'=+X;Tz-CC~+b,eMKqdo8: bSCWTSR#RîoXuZZw+8mISs Fy]܎Zߙ-*! N)-g*<+IIQdROrμѢDX@3_ 5TݗPǵN88)Z~ + 85C$r|ŽyrRV!%˝/@q;J r7T;Q˛[:.VpBtKpn98GTV])wJOqj °Jf4#FZMnM^1-ϥDF8~u[G"2ua'_9?m^X+\9 q`UΪv†diԓ4RVM!!loARBJ9.Lˑvŵ rA3I]qiHmN:@TX%rdHQeҥdEt$xX6˭dBPRrq O!T]tQu3|b'Vq%֎)RO ?u")O)in.hi-6[vqq}SRO%N8f So\6C $^t7ISy7Ǡr "JlPk?3m3ƛ*Jюp#<NLѵԍr`s z+V)=}BϪe*!6.`o(RfG YZFڅ%͢J!q0IZ 7S֕qvi;xvNͅeUkzcjTP- $!Yf03n'R*FQ]5]mw3yoeryXqN6V@ -?"A5jEjy߱%y ]ג{Tշ&p4%vhlfxm~zDu!]x-F_᫘&0Dž9 r5=";44(! z$2ksrz$ЙsT,VP @(0ڪޛťN+sZy]M]XDʱDaPH#Rq$@U@B~rVn qVa%q IJ̿#C!HqK8wŀ NpOJ0FK ţmo|Ҭn@*S[]ѝ){,9 / >|jȉ:Os{Fi7nsbEfǃ(%>E IʆyX9J#)n sJ]i.np$G$'#uGa;\;Bn-hJ f3,0qmRpOCFkrcmˍ-/c)q瓁SFrCi_GydсV]u*-, nNNpAGdGcA-gs~[m$u*88V-H IRqL9m%"دRŲ])PFZķў jJtVĘ̄MK\m_2kjyri5IIuiY݀,WNqI&sJ.0 9=<}4OW(PGθk#zs7]xC$\P[P~4:fE1[)(pTwg p<65Ǘ. _ؔ\4Ԅdx Jrg=qZigO/]\*Wnrq,dG <ԀJ|y 7" Wv?>2eHRܳ ^O6Jxt%Xޢr~s|F&K>d{>nS:Q\gKns! ʳI'jVʄ]*ץi:!T5 MA'pR9?s3q<uMv]Es(V-BpH}g(a8JV&{'jRhJێdO{Uv*iy]jq -֛C{H]IvS0 чj5&nMoƥ6!KFsik5tg[(9!iyIrTH󚚙{'q1קWFw'Ķ.s~Lpe ZPޥen(he+^'XNV^yיYwMaKkP I ڠ5F- 6$Kzd!HlpO'wJȖu+j$ cJvvRV,1-,~]jbF2@򬤵.~HP @coWAJ$iN7W))X3U9r!I\j>BB˜pӍI'BUyO5 `m!'?]1nLTpO?uNK+3-mTm*9HIK3NVs;i°Y#mM(,Fq\g%Qٟs8^2oGmŧ }M_!.`2Z6cvݨ瀤 QWUޥjUI-u^}gqƸ*Tyl7! HRs]RwI(:sp轨ʱO51;܇U `VӶewcw[ƌ˧BJ4O)–Y-'r}h5Te?\ۆƑrA>-9%=ā[R6QG {ẕլ7Em6C$,KJ8OgIvf缏f5SӻU #72Md2a%IPOBF=F7J-N9i] um>ԯnOy/=QܥH*ڐpIޜ@-6Ӎ%ō~4}R+ H>g*[$h^)Fw&mQ4乲ԗ Dp Ce9TJ3qSK3EjѩUEUUoSU7f!?xrdxHHڞ3} Z1n61W EcYsSհ`ɪqzWt5pJ%ڧcei E'=Ea*rgT(T%2 5V) SAYD9罎y>T:ڜ\c0TYKfx8m ]K`8*ϥiNԤsOw(ug5ߤϳ6\F;R>`2k+ٚݿPݟVp]9 @Rz(dP^:cRjKpJ=gti+VRӟEZrhtT %DŽ;^0nJUǽOS=TZnd~"+^N\v{ a{񌤂㜒u")W^qEf6Z XZBąpy$Aj\Ѥja4Y*\9*黴t?n8 AUNjH:j_?]Nl(}.w% ڂBq(NF U)3I:i<jxU۔6%,}R(H )c7dU#JUSkCvZq$خ-18S9p1z+*qURVf#4+6&mkׂeŠ?UWr:'Qxy3.$Z[}JiP?<ŸсmRSxJUԲ9 bC%AԖvqzLI ڏrV9ffkG\ 8W*7G26w R-,Ih6OO2zsSRݓSg{eLEK5 G7nL{lgkWwPTR >"aƜ^R#֨qtG<#\9Z&2OHꮛw aO"BC2(ˑ]'u=Q CIozosAP'B72?7?UˡG~6zP|ΌVT8Rpk+;#DRE !닰_z~__Y]JzCRn67! )-;26HS;Ya$׸m:K,sݡN`p33˩U Q B[z2! !ќ׃Q鵺([)r9h ,Nz=1:!+-`+ R}@JJz @ SoCkoN4>j[dJ0p*/rRn}  y2 Tdä%J*zsW\]]rYW|fD2mT^]om}da);-~sM(n8|Kn--.a`9* 9 `hu$*[z>iWoG5?L&[ˊhIalw$#'gsK$d,o\vàwSk A8JFNyJO;mA"yM-aٳ)R@zHĒqΡב[$Ėt^E]qO+*{ApspH99JEy<;YS /0wI$0< %לO4dJ9(51ljSkHVqeeѪuM8 V]JJz;38g*]JxW HdJYc kN\CYITs x !Sm+cN uey&j;.i!ܩFxNU0ʜзNwSR[mu tĻyhLaBlk[]t xAIlqE]n_ŦK,]<H@yAMWH +7R„+7m7, jvV*j 9)YVrzv׹oEtC#ʑoPٓ*[{iqAU-iEIAԾ'i\z }춄0gsvR1O[}J5K'é\vqSqVb󅰄%Qpc9ȪY8n&ISv]72]Kf4 ex"h;AJvx߆ {:-I=+ B<.>p֌erM/z1vͬ/zGE.ѥۃv"rͺG|8GښRrM6/Z TQ$Խm;䬽4fZe/;geG!1"2R+* ~5Ql_V#+Jmi}/,:kKb룶󖛌d[ƐِK$+AUEوURSY/n&l*毺P3smz~7Yn,r, :6=jnsajqR'wu+g\-*0զ+r%G譣<,uUSQ96&<@f~,pol 炞q]JO:3._Ik} [Ho.! I '>6cs|!%_Vh)i[~kRyi@BоjNGR5z8 O4ދ/_dLܰ"*?7ɩlXuT /F䑑^Y&kv#~#׉va e NLyh{KvE4f"-3.NxPJQ@F1T!3QmkKI17zQBnꢂ|G\ԷVO"Rr޿bkeї9$YVPF8ry 38g]tʺجeŚo!-.;ogN7!D8>|u֛j9npurH@ZI#J=s.2*bin-(@AkIHۊpHe=CJꜞj`߹{./{9*3|\CvP-3$!@E㟵IHc:}4[neQKq6HTx8[,-Kn.94ȓoQ6[v?%kX\ W>&<57VbՏነQ/w4{~9ջHZޭþqMSø$l n`>Ю;}4[t4:ЈҢ8*Z18<]<*o՗\gYY,,Nء 茽.f=љ ,>‹@H'}&6;Tg5kJj{a,ܞC =n %g$R18ulW5'Y屪5{mˌa8B/ܐ9 ^+M|+jzw;_k}AGAW2y)ȬZ:`GiMM/5qZ q$^9Nգ=RFz2A?Z KyVm\UmR<\J.pjb&4y)Bd  83ЏZؔػPAjTxSYm!ą5rc'tcE=h4yʢb&GvoúݴǙ%ךBu YZViN9,|1y<AkM{T2I0ѣ N&Zʹ WWB0LtAsxVFRho¸*ٻqTgpc[.7fb閍Q97NKg0>IJ w\[-߉nV.:_gy-8 R1ץk[=K@iM*kl S(݇^]P 3\uS{άTjM{.}b6kILvϐ,KnHZ ^ik<%Zu+և(P× NűV\<互Gv;@'#;;RsC6bZV%JG Jwp*J[uo53$YH/8>llxpZ_Dn#!5%DeJy';sU)^$*WwG5?LΦev8NDu qKBJ*< }*`$q}1oGʗ8[\> NUUٯ?+1:NK1KeL)iS$w 8%m?&6 q/fiPq[*lxd)$9EWzi472;֮›+NGRBJJw0O\c$U.'BcTPC.)CM!$z Ԅ5m=\rfNAA2@>.zكjp:/rKS3ϞIjJ `'vK>бoL5K,²2p3'ֽ,g~k]GrDaNmZHI T`Z.[qqsKd%eH>Uu`IbiGG$db 8Dq-" nIP;;JA9刂v0Y:$2`7”H@KiN{¬FxEU`ˊady]W(qӯ\ !KPWHi=~(C;E]%{^OO~- NzjIڣ=3k$3U$׻%I9=t˺ݭ.tӾ]N2hVHqu1mO}T<>LдΟJb&,i--u RVAR@v\"Ew#61%#QjҲ`EqNHԥR }VXY0cGTxAAVxJc*f MY\8H`"KO*NO0?X U5_VQ)awMikHNA4 N6?ԙmYa{( 3ϡVkZhr,&֧%go[xeWФd66=R:x ƛhiFvםMh IAndޖ Κ>RUⳒaO$ 'jҖ]ڙjk+pueKjVҢP Q:&.hXw}e7 |J]O 5(! vSNR~OQIA”ӡc=9,Ϣb) RJU)_`[ij\m.zT8 3VZVZŖk]%[,6#j|ҹdggNi嶤Uv2alˡD`PTiXPPP @("3eQKIl)/NNS|F*`FS,ϛ.}sgko-w9*$8ipVU]& [AN$ϮAGZѫ~κv6J):S̢%$\NTcjFYr0>"U5~ZۗqPBgvI>KW7쌮{KP)RTs欫.r8bWxjIs0c[˫b>Ĩw{r\q\,L#|4LMK#v {C.[}*׼#+;v`q<ՕGSV|Ub;*+>\q/}{P\Ca ]+8ZyG˝\qem֭%=TN8g} _{wK\9sV76ަlBHuIR?O3VNG5ZպɮaEw~T~oS_i[/6q%+BB 1PsZv K5qО6}GȚ'B4v#Gne6ޥ}wQ\py)n>J$=|JtթKoYL.\5-4YޕQQʸ |kt;qؙP*gcvh7H +*; )IQZVnђ8V-;8+ampK!7݇KY9P#j})_])׫w "KIMpZRRUwA)9 kEyIq@P @[wRgݹ^ػxՊWI jT~ -27q>=+zI0𯀧ZwsZP\Xz-oKl-N%o)滼gqRݷr:dI4M؊\4j^ҷM,6i=ut#$iS-6RZ܂H: nMlgB:)FֶuuC76U%ISrq%D'8 )%$)ӕI>ѥm,k♈k\Ucll@;Sw)\FtҡIDv>%YK++r>]$,x GACixH$>[ɋnݢvti֕,񤸒i^|`y8ggSo:vϫퟣ}?՚~}+5*#uJiJIi%) d ܏{f݇zFkX]ߕc6P @(h% `gPGb!73!pˬ6KW78>`e%fkF<7Q2,(1![hJZ@BA0 =NO)Iʑ"NT)n{jTEۋMJ `Qʫ'ő,t״>2I-FqO8vHRȬ' Io_ܼ'2򸳖<ƚ/N _KiY>~ۑb@(%CĐh㻟 ll!} tVWv4=`/'UCO @̈76=s ktWgj #2F~)<~X'_eBL;ݚbC@Ԕ/QoJ ̨睦v;{A5sÒ 1\dڕyOC14M:ѧGW\e%qhkd =/\bsWg0~ @Jlr{6䟇Zb~SY ;=ݻ!R*enڔ1!Q 8ڸ#sҮM_>Ԩo1lvytTLÜd]S;NJPGLqfXF']cm5L^4jQ푭{0Z%{Яi A>HjGb{M Jp2% IpigRV?Ψ}P8Fph/qh V׋ыT-^]5SynK[jHOx j sXhN9`#jPӈ~v*]{y(nW;TFw?X4u_6.-ړ֞K佱+!D)xs)|?5 m_FCvQ,"R[Zk*q./p9mIQG^%fo-(kR[!Ҡ,$7şYzMHcsDZiaii{̑Zܥ*VU*E4jj:]6ע;-ƞ ݒjc5k4s8>ﰻj5$$FSiNv!# OQ(9gp?%F]yN>׶;-G9%4wx(ʝlH˖qthl;VNܵfdAZ~Ԉ: ,~D5:vmMJ@ oKy[B :R}t"DIgGP~a?שAI)@G{^z{$wdgݠԼ<U5X G8OUVOj)@g #1G;+K*#4keŖL^EMR=ZI2G^ C=$߹/՗>C8?m܏N+S=5~t` -+oN eMTHe .MtV)meFEtl )q_zj%^-Kfda ;aÏtM+6Jr䊂@(P(IPT0G1Y̛TVRٗU&MI^!&2XZU~bXG]-Jؽ'D-u y;BMGkWmAʩɆDTa-\?57~Nz_dXr#*h2lMjcH_jIPq3>?Or; oju%tECrNI(Jp1TBmI?Mj.#4޿Vu!*cR[uɐ`RkKm?[=",TIiԫ?,8˚0IY\v;agjDB\d[ YUOb<7&bJ.,i C̡h9Gfj:hr AiehSf0%r$>e>]pÜ)P><:O6܌RٜRnSy K~AP'z㯘*Z&i'llz6lAnNbrP<[x )SF"9fsvo{ubHSI KL;֒>=psZFtpIm'<ŕެ!Kl/* @cx9ʾٖj~7ﯼS!Će(mII8H#x=zdT[5G, z*d &; K)ޥ$ $RJ@/ QI'mI Joݓ]Jfn]i)}6u'’H<~I>ujZl%<4rU(Q<J@O ?+U ڎ &f}N nh'"rx2y*Z\[nR[ٚK%Ȉ#/ ZӹX F] qJpOzH!m - *BXk #!4;O_“2v)nm!$FZ[AQR A*u"&/=(J9e'QI $ ֨M3Z Cf[m. RY5gbZ.Y9&:O~Zv築Ww3WG~\4s~8h=L[Z%$Lw(F`?%WYֱkR^/,#r.Ur9Kғ6 ,D֪܍[Bi0IT;]TF7$d$;SWOK4qz\*/?jBJaa8C;zJ2L+ RBK.4 VTpH>j-]De 6KP!::!^eQ@Nԥ[SpO -=H5HYlJzI"ʊ%hBT:xsYSezdWAZ]iᄺAPI#sTi^u @(fCZ >;A-Z7HRH>GUI=I:6ws1ref!H_x":AJS`ppHϡvxU[CkZI$zY' iRR?۶iXrA 'pzdϨԺ[(, 6[ 6*I=HBJPTWB7X @(P @(P @(P @(P @(hpai,< oP!p@Y;])Ҵ^!ɭ)v7ZӵeRARAlDmd/IJSxPZz% QLz'EPQ*$'wZ[[ꤊ@(hJ:MRg<:fW!>t93WΈԄ*< 9QfQ+6]ueHNo!"֙| (亓f{6$:K\H8Jϖԁ~jDɊ̰P @(P @(P @(P @(P @(<Nդ(|h L wZ_\{DY*:+I$P8UNeԋ2k)ڸ.KٞR@ϰ<|? 9(^먺MqcAP%MnǠ>_:R-̫HKm% %#VOR@(P@9P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @(P @( endstream endobj 17 0 obj <> stream xc``2ptqre``+) rwRR` ``\\yy 5F}Yd<^\PTQJjq2]^Rgd$e@좐 g ͗a_ ' v@t0l-bVep/,L(Q0200PpLOJU,.I-VK/*/J,IM ! A!ahiiI P<@X(v!ɥEePa>Œ9 KX Lz00OE2030ïPo endstream endobj 4 0 obj << /Type /XObject /Subtype /Form /FormType 1 /Filter /FlateDecode /BBox [0.000000 0.000000 595.276000 76.535433] /Matrix [1 0 0 1 0 0] /Resources << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F2 5 0 R /F1 3 0 R >> /XObject << /I0 15 0 R >> >> /Length 197 >> stream xKkBA WeI&ڊU/ nʥBf8A3!(X4`JQj*Aj͕197f hkL[=µrw]F D%x2WC0 9)Z ^Wh}29yyu?4g=bT1߻a endstream endobj 2 0 obj << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F1 3 0 R /F2 5 0 R /F3 9 0 R >> /XObject << /XT4 4 0 R /I0 15 0 R /I1 16 0 R >> >> endobj 6 0 obj <> /H /I>> endobj 7 0 obj <> /H /I>> endobj 8 0 obj <> /H /I>> endobj 10 0 obj <> /H /I>> endobj 18 0 obj << /Title (FDA OKs immune-boosting drug for advanced bladder cancer) /Subject (FDA OKs immune-boosting drug for advanced bladder cancer) /Creator (Science X Network) /Producer (TCPDF 6.3.5 \(http://www.tcpdf.org\)) /CreationDate (D:20210618155525-04'00') /ModDate (D:20210618155525-04'00') /Trapped /False >> endobj 19 0 obj << /Type /Metadata /Subtype /XML /Length 4769 >> stream application/pdf FDA OKs immune-boosting drug for advanced bladder cancer FDA OKs immune-boosting drug for advanced bladder cancer 2021-06-18T15:55:25-04:00 Science X Network 2021-06-18T15:55:25-04:00 2021-06-18T15:55:25-04:00 TCPDF 6.3.5 (http://www.tcpdf.org) uuid:0b740604-f085-afec-aba6-5b854b2fc950 uuid:0b740604-f085-afec-aba6-5b854b2fc950 http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema internal Adobe PDF Schema InstanceID URI http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 20 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [11 0 R /FitH null] /Metadata 19 0 R >> endobj xref 0 21 0000000000 65535 f 0000003352 00000 n 0000051892 00000 n 0000003419 00000 n 0000051391 00000 n 0000003525 00000 n 0000052049 00000 n 0000052299 00000 n 0000052547 00000 n 0000003636 00000 n 0000052832 00000 n 0000000015 00000 n 0000000491 00000 n 0000002072 00000 n 0000002549 00000 n 0000003750 00000 n 0000009386 00000 n 0000051009 00000 n 0000053050 00000 n 0000053546 00000 n 0000058398 00000 n trailer << /Size 21 /Root 20 0 R /Info 18 0 R /ID [ <0b740604f085afecaba65b854b2fc950> <0b740604f085afecaba65b854b2fc950> ] >> startxref 58608 %%EOF